As of May 23
| +0.18 / +0.55%|
The 5 analysts offering 12-month price forecasts for Albireo Pharma Inc have a median target of 50.00, with a high estimate of 92.00 and a low estimate of 41.00. The median estimate represents a +50.92% increase from the last price of 33.13.
The current consensus among 7 polled investment analysts is to Buy stock in Albireo Pharma Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.